CV Sciences CEO on How CBD is Being Regulated in the U.S.

CBD is legal in 50 states, but how is it being regulated?
Publish date:

Do you even know what CBD is? 

Let's break it down. 

It's not the thing that gets you high--that'd be THC. CBD, or cannabinoid is the stuff used when you have a medical condition, such as epilepsy, PTSD, chronic pain, etc.

CBD is also what's being referenced when someone is discussing cannabis medication for dogs. 

CV Sciences, a company that focuses on CBD products, was at Jim Cramer's teach-in, which had a heavy focus on cannabis. 

CV Sciences specializes in CBD pills and oils. 

CEO Joseph Dowling sat down with Action Alerts Plus analyst Zev Fima to discuss the different business regulations that CV Sciences faces. 

CV Sciences is publicly traded in Canada under the ticker (CVSI) . The company focuses on CBD research. CV Sciences runs two different divisions: pharmaceuticals and consumer products.

CBD is currently legal in 50 states. And, Dowling told Fima, CV Sciences has "2,000 stores" across those states. He added, "We have a very robust direct-to-consumer e-commerce business."

Since CBD is derived from marijuana, the sourcing can be tricky. In states where marijuana is legal, CBD must be sourced from authorized marijuana. In other states, however, CBD must come from industrial hemp.

It's currently developing CBD-based drugs that have the potential to be approved by the FDA. The CBD pills and oils that CV Sciences currently sells are both part of its consumer products division. Both products are derived from hemp instead of marijuana. 

This interview was sponsored by CV Sciences.